Article ID Journal Published Year Pages File Type
8773893 Kidney International Reports 2017 32 Pages PDF
Abstract
In this study, AAEs were common but well tolerated in ADPKD patients on tolvaptan. ADPKD patients in earlier stages of disease progression may be more sensitive to aquaretic symptoms, which may help in guiding tolvaptan dosing and titration decisions in the future.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4
Authors
, , , , ,